Applied Genetic Technologies Corporation logo
Applied Genetic Technologies Corporation AGTC

Quartalsbericht 2022-Q3
hinzugefügt 21.11.2022

report update icon

Applied Genetic Technologies Corporation Anteile 2011-2026 | AGTC

Anteile Jährlich Applied Genetic Technologies Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
45 M 32.8 M 21.1 M 18.2 M 18.1 M 18.1 M 17.8 M 16.3 M 3.57 M - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
45 M 3.57 M 21.2 M

Anteile Vierteljährlich Applied Genetic Technologies Corporation

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 64.9 M 51 M 43.6 M 42.9 M 42.8 M 42.9 M 36.8 M 25.9 M 25.8 M 25.9 M 25.8 M 18.2 M 18.2 M 18.2 M 18.2 M 18.1 M 18.1 M 18.2 M 18.1 M 18.1 M 18.1 M 18.1 M 18.1 M 18.1 M 18 M 18.1 M 18 M 18 M 17.2 M 18 M 16.5 M 16.4 M 15.6 M 16 M 15.6 M 109 K 109 K 109 K 109 K - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
64.9 M 109 K 21.8 M

Anteile anderer Aktien in der Pharmaeinzelhändler

Name Anteile Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
33.4 M - 2.43 % $ 254 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
15.8 M - 2.71 % $ 14 M usaUSA
AbbVie AbbVie
ABBV
1.77 B $ 232.08 3.29 % $ 411 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
299 M $ 3.61 0.56 % $ 1.08 B canadaCanada
Abeona Therapeutics Abeona Therapeutics
ABEO
21.4 M $ 5.12 -1.54 % $ 109 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
166 M $ 4.66 -0.85 % $ 773 M canadaCanada
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
166 M $ 24.56 -0.32 % $ 4.07 B usaUSA
I-Mab I-Mab
IMAB
187 M - - $ 866 M chinaChina
Achieve Life Sciences Achieve Life Sciences
ACHV
19.8 M $ 4.56 -3.59 % $ 90.4 M usaUSA
AC Immune SA AC Immune SA
ACIU
75 M $ 2.93 -1.01 % $ 229 M schweizSchweiz
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
219 M - - $ 40.3 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
1.08 K - -10.17 % $ 12.2 K usaUSA
Aclaris Therapeutics Aclaris Therapeutics
ACRS
123 M $ 2.87 -8.31 % $ 352 M usaUSA
Biophytis SA Biophytis SA
BPTS
118 M - -13.47 % $ 169 M franceFrance
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
78.2 M - - $ 1.01 B usaUSA
Adagene Adagene
ADAG
56.3 M $ 2.96 -4.67 % $ 167 M chinaChina
ADC Therapeutics SA ADC Therapeutics SA
ADCT
76.7 M $ 4.1 -0.73 % $ 105 M schweizSchweiz
Adial Pharmaceuticals Adial Pharmaceuticals
ADIL
6.47 M $ 2.53 - $ 16.4 M usaUSA
ADMA Biologics ADMA Biologics
ADMA
238 M $ 15.57 2.57 % $ 3.71 B usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
152 M $ 16.02 -2.67 % $ 2.43 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
4.58 M - -1.52 % $ 24.7 M usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
13.2 K $ 0.46 -4.63 % $ 6.06 K usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
80.5 M - -18.52 % $ 27.3 M britainBritain
Agenus Agenus
AGEN
358 K $ 3.33 -0.89 % $ 1.19 M usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
58 M $ 30.23 0.83 % $ 1.75 B usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
48.1 M $ 0.91 -8.59 % $ 43.8 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
257 M $ 1.31 -0.76 % $ 337 M usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
23.9 B $ 0.24 -8.87 % $ 5.73 B britainBritain
ARCA biopharma ARCA biopharma
ABIO
16.8 M - 1052.0 % $ 415 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.24 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
12.1 M - 4.01 % $ 150 M canadaCanada
Aldeyra Therapeutics Aldeyra Therapeutics
ALDX
60.1 M $ 5.46 -0.73 % $ 328 M usaUSA
Alector Alector
ALEC
103 M $ 2.43 -5.08 % $ 250 M usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
64.3 M $ 7.03 -6.27 % $ 452 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
19.8 M - - $ 86.2 M usaUSA
Alkermes plc Alkermes plc
ALKS
165 M $ 30.1 -2.05 % $ 4.96 B irlandaIrlanda
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
75 M - - - russiaRussia
Allogene Therapeutics Allogene Therapeutics
ALLO
157 M $ 2.78 1.83 % $ 436 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
6.18 M - 1.93 % $ 17.4 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
131 M $ 332.92 0.51 % $ 43.6 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
67.1 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
34.4 M - 0.23 % $ 488 M usaUSA
Altimmune Altimmune
ALT
71 M $ 4.31 -3.36 % $ 306 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
19.2 M - -0.23 % $ 916 M usaUSA
ALX Oncology Holdings ALX Oncology Holdings
ALXO
52.2 M $ 2.11 -10.21 % $ 110 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
68 M - 3.16 % $ 1.9 M usaUSA
Amgen Amgen
AMGN
538 M $ 388.16 2.33 % $ 209 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
17.9 M - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
5.01 M - 4.14 % $ 49.1 M usaUSA